-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Maintains Outperform on ModivCare, Lowers Price Target to $10

Benzinga·01/14/2025 17:56:16
Listen to the news
Barrington Research analyst Michael Petusky maintains ModivCare (NASDAQ:MODV) with a Outperform and lowers the price target from $25 to $10.